Kidney cancer
1-minute read
Follow the links below to find trusted information about kidney cancer.
Last reviewed: July 2016
Need more information?
These trusted information partners have more on this topic.
Found 1250 results
Kidney Cancer (Renal Cell Carcinoma; RCC) | myVMC
Kidney cancer, or renal cell cancer (RCC), originates from the cells of the outer layer of the kidney, the renal cortex
Read more on myVMC – Virtual Medical Centre website
Kidney cancer - Cancer Council Australia
Find out information about kidney cancer, including incidence and mortality, screening, symptoms and diagnosis, causes, prevention, treatment and prognosis.
Read more on Cancer Council Australia website
Types of Kidney Cancer | myVMC
There are many types of renal (kidney) cell cancers (RCCs). Each type of tumour is derived from a different cell type within the kidney and has its own distinct characteristics.
Read more on myVMC – Virtual Medical Centre website
Kidney Cancer (Renal Cancer) | myVMC
Renal cell carcinoma is the most common form of cancer that originates in the kidney. It occurs due to the mutation of cells in the kdiney's filtering system.
Read more on myVMC – Virtual Medical Centre website
Renal cell carcinoma (kidney cancer) treatment information | myVMC
Kidney cancer or renal cell carcinoma can be treated with nephrectomy (surgical kidney removal), chemotherapy and targeted cancer therapy.
Read more on myVMC – Virtual Medical Centre website
Kidney Cancer - Information, Treatment & Support - CanTeen
Kidney cancers affect the organs that process waste from the blood in the body and produce urine. Learn more about causes and treatments with CanTeen.
Read more on CanTeen website
Kidney cancer | Kidney Health Australia
Read more on Kidney Health Australia website
Kidney cancer | Kidney Health Australia
Read more on Kidney Health Australia website
Kidney Cancer (Renal Manifestations of Malignant Disease) | myVMC
Renal manifestations of malignant disease occur when cancers outside the kidneys, including leukemia and lymphoma, spread and cause kidney cancer.
Read more on myVMC – Virtual Medical Centre website
Nephrectomy | myVMC
Nephrectomy is a surgical procedure involving removal of a kidney and can be indicated for both benign and malignant conditions.
Read more on myVMC – Virtual Medical Centre website
Found 52 results
Targeted drug therapy for advanced kidney cancer | Cochrane
Cancer of the kidney is an important health problem with over 15,000 deaths in North America annually. Kidney cancer in adults that has spread or is too advanced for surgery is incurable and is resistant to conventional chemotherapy drugs. Drugs that affect the body's immune system have been standard care in the past two decades but have been associated with unpleasant side effects and poor results in most patients. Recent advances in understanding the molecular biology of kidney cancer have resulted in the development of drugs that target known molecular pathways (targeted therapy). This review critically examines reports of clinical trials that have directly compared the new targeted "designer" drugs with previous standard therapies for this condition, to see if these drugs could be considered an advance in care.
Read more on Cochrane (Australasian Centre) website
Immunotherapy for advanced kidney cancer | Cochrane
Read more on Cochrane (Australasian Centre) website
Surgical management of localised renal cell carcinoma | Cochrane
Read more on Cochrane (Australasian Centre) website
Surgery for upper tract transitional cell carcinoma | Cochrane
Upper tract transitional cell carcinoma is an uncommon cancer mainly affecting the draining system of the kidney (kidney pelvis) and ureter (the tube through which urine passes from the kidney to the bladder). The main treatment approach for this condition is surgical removal of the malignant area. There are a number of surgical techniques for this procedure and the aim of this review was to compare them and determine which was the most effective in terms of surgical ease, patient morbidity, clinical outcome and cost. Our search of the literature found no high quality evidence comparing different surgical techniques. Evidence from one small randomised trial and observational studies suggests that laparoscopic surgical intervention may reduce blood loss, post-operative pain and hospital stay. However, the quality of the evidence is poor and, therefore, it is not possible to recommend the most effective surgical procedure to replace the existing clinical practice for managing upper tract transitional cell carcinoma.
Read more on Cochrane (Australasian Centre) website
Immunosuppressive agents for treating IgA nephropathy | Cochrane
IgA nephropathy is a common kidney disease that often leads to decreased kidney function and may result ultimately in kidney failure for one-third of affected people. The cause of IgA nephropathy is not known, although most people with the disease have abnormalities in their immune system. We identified 32 studies enrolling 1781 patients that met our inclusion criteria. This review found that if people with IgA nephropathy receive immunosuppressive drugs, particularly steroids, they may be less likely to develop kidney failure needing dialysis or transplantation. Few studies were available and the harms of therapy are currently not well understood. Larger placebo-controlled studies are now needed to be certain about the benefits and hazards of steroids on outcomes in IgA nephropathy and to identify which specific patients might benefit most from the treatment.
Read more on Cochrane (Australasian Centre) website
Increased water intake may help reduce the risk of recurrence of kidney stones but more studies are needed | Cochrane
Increased water intake may help reduce the risk of recurrence of kidney stones but more studies are needed
Read more on Cochrane (Australasian Centre) website
Which therapies are the most effective to prevent the progression of autosomal dominant polycystic kidney disease? | Cochrane
Which therapies are the most effective to prevent the progression of autosomal dominant polycystic kidney disease?
Read more on Cochrane (Australasian Centre) website
Laparoendoscopic single-site donor nephrectomy (LESS-DN) versus standard laparoscopic donor nephrectomy | Cochrane
Laparoendoscopic single-site donor nephrectomy (LESS-DN) versus standard laparoscopic donor nephrectomy
Read more on Cochrane (Australasian Centre) website
Treatment-related early and late side effects on the kidney in survivors of childhood cancer | Cochrane
Read more on Cochrane (Australasian Centre) website
Treatment-related early and late side effects on the kidney in survivors of childhood cancer | Cochrane
Read more on Cochrane (Australasian Centre) website
